May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)?

被引:13
作者
Scarpa, Raffaele [1 ]
Caso, Francesco [1 ]
Costa, Luisa [1 ]
Passavanti, Saverio [1 ]
Vitale, Maria Grazia [2 ]
Trojaniello, Claudia [2 ]
Del Puente, Antonio [1 ]
Ascierto, Paolo A. [2 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, Rheumatol Unit, Via Sergio,Pansini 5, I-80131 Naples, Italy
[2] Ist Nazl Tumori IRCCS Fdn Pascale, Dept Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy
关键词
COVID-19; Immune response; JAK-inhibitors; Monoclonal antibodies; Passive antibody administration; SARS-CoV-2; Spanish influenza; Antiviral therapy; Biologics; Vaccines; RESPIRATORY SYNDROME CORONAVIRUS; CONVALESCENT HUMAN SERUM; MESSENGER-RNA VACCINES; PROTECTIVE IMMUNITY; NEUTRALIZING ANTIBODIES; SARS-COV; SPIKE; TOCILIZUMAB; INFECTION; PNEUMONIA;
D O I
10.1186/s12967-020-02673-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background In 1918 an unknown infectious agent spread around the world infecting over one-third of the general population and killing almost 50 million people. Many countries were at war, the First World War. Since Spain was a neutral country and Spanish press could report about the infection without censorship, this condition is commonly remembered as "Spanish influenza". This review examines several aspects during the 1918 influenza pandemic to bring out evidences which might be useful to imagine the possible magnitude of the present coronavirus disease 2019 (COVID-19). Methods In the first part of this review we will examine the origin of the SARS-Coronavirus-2 and 1918 Spanish Influenza Virus and the role played by host and environment in its diffusion. We will also include in our analysis an evaluation of different approaches utilized to restrain the spread of pandemic and to treat infected patients. In the second part, we will try to imagine the magnitude of the present COVID-19 pandemic and the possible measures able to restrain in the present environment its spread. Results Several factors characterize the outcome in a viral pandemic infection. They include the complete knowledge of the virus, the complete knowledge of the host and of the environment where the host lives and the pandemic develops. Conclusion By comparing the situation seen in 1918 with the current one, we are now in a more favourable position. The experience of the past teaches us that their success is linked to a rapid, constant and lasting application. Then, rather than coercion, awareness of the need to observe such prevention measures works better.
引用
收藏
页数:12
相关论文
共 132 条
[1]   Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic [J].
Ahmed, Rafi ;
Oldstone, Michael B. A. ;
Palese, Peter .
NATURE IMMUNOLOGY, 2007, 8 (11) :1188-1193
[2]   Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) [J].
Ahn, Dae-Gyun ;
Shin, Hye-Jin ;
Kim, Mi-Hwa ;
Lee, Sunhee ;
Kim, Hae-Soo ;
Myoung, Jinjong ;
Kim, Bum-Tae ;
Kim, Seong-Jun .
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2020, 30 (03) :313-324
[3]   Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study [J].
Al-Tawfiq, Jaffar A. ;
Momattin, Hisham ;
Dib, Jean ;
Memish, Ziad A. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 20 :42-46
[4]   Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome [J].
Arabi, Yaseen M. ;
Mandourah, Yasser ;
Al-Hameed, Fahad ;
Sindi, Anees A. ;
Almekhlafi, Ghaleb A. ;
Hussein, Mohamed A. ;
Jose, Jesna ;
Pinto, Ruxandra ;
Al-Omari, Awad ;
Kharaba, Ayman ;
Almotairi, Abdullah ;
Al Khatib, Kasim ;
Alraddadi, Basem ;
Shalhoub, Sarah ;
Abdulmomen, Ahmed ;
Qushmaq, Ismael ;
Mady, Ahmed ;
Solaiman, Othman ;
Al-Aithan, Abdulsalam M. ;
Al-Raddadi, Rajaa ;
Ragab, Ahmed ;
Balkhy, Hanan H. ;
Al Harthy, Abdulrahman ;
Deeb, Ahmad M. ;
Al Mutairi, Hanan ;
Al-Dawood, Abdulaziz ;
Merson, Laura ;
Hayden, Frederick G. ;
Fowler, Robert A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (06) :757-767
[5]   Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 [J].
Arshad, Samia ;
Kilgore, Paul ;
Chaudhry, Zohra S. ;
Jacobsen, Gordon ;
Wang, Dee Dee ;
Huitsing, Kylie ;
Brar, Indira ;
Alangaden, George J. ;
Ramesh, Mayur S. ;
McKinnon, John E. ;
O'Neill, William ;
Zervos, Marcus .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 97 :396-403
[6]   Presumed Asymptomatic Carrier Transmission of COVID-19 [J].
Bai, Yan ;
Yao, Lingsheng ;
Wei, Tao ;
Tian, Fei ;
Jin, Dong-Yan ;
Chen, Lijuan ;
Wang, Meiyun .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14) :1406-1407
[7]   The site of origin of the 1918 influenza pandemic and its public health implications [J].
John M Barry .
Journal of Translational Medicine, 2 (1)
[8]   Harms of public health interventions against covid-19 must not be ignored [J].
Bavli, Itai ;
Sutton, Brent ;
Galea, Sandro .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
[9]   Covid-19 in Critically Ill Patients in the Seattle Region - Case Series [J].
Bhatraju, Pavan K. ;
Ghassemieh, Bijan J. ;
Nichols, Michelle ;
Kim, Richard ;
Jerome, Keith R. ;
Nalla, Arun K. ;
Greninger, Alexander L. ;
Pipavath, Sudhakar ;
Wurfel, Mark M. ;
Evans, Laura ;
Kritek, Patricia A. ;
West, T. Eoin ;
Luks, Andrew ;
Gerbino, Anthony ;
Dale, Chris R. ;
Goldman, Jason D. ;
O'Mahony, Shane ;
Mikacenic, Carmen .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21) :2012-2022
[10]   Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein [J].
Bisht, H ;
Roberts, A ;
Vogel, L ;
Subbarao, K ;
Moss, B .
VIROLOGY, 2005, 334 (02) :160-165